Table 1.
Characteristics of the patients who underwent venous reconstruction
| Variable | All patients (n = 90) | Patent (n = 74) | Thrombosed (n = 16) | P-value |
|---|---|---|---|---|
| Age, median (IQR) | 67 (55–73) | 68 (59–74) | 63 (51–70) | 0.108 |
| Male, n (%) | 54 (60) | 43 (58) | 11 (69) | 0.576 |
| Pre-operative vein invasion, n (%) | 58 (64) | 46 (62) | 12 (75) | 0.399 |
| Neoadjuvant chemotherapy | 20 (22) | 15 (20) | 5 (31) | 0.337 |
| Histology, n (%) | ||||
| Adenocarcinoma | 67 (74) | 56 (76) | 11 (68.5) | 0.582 |
| Neuroendocrine | 17 (19) | 14 (19) | 3 (19) | |
| Other | 6 (7) | 4 (5) | 2 (12.5) | |
| Operation, n (%) | ||||
| Whipple | 73 (81) | 60 (81) | 13 (81) | 0.556 |
| Subtotal | 12 (6) | 9 (12) | 3 (19) | |
| Total | 5 (13) | 5 (7) | 0 | |
| Lymphovascular invasion, n (%) | 50 (56) | 42 (57) | 8 (50) | 0.782 |
| Nodal disease, n (%) | 65 (72) | 55 (74) | 10 (63) | 0.365 |
IQR, interquartile range.